The warts therapeutics market size has grown steadily in recent years. It will grow from $1.96 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to salicylic acid use, cryotherapy development, topical treatment evolution, surgical interventions, the emergence of immunotherapy
The warts therapeutics market size is expected to see steady growth in the next few years. It will grow to $2.4 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to precision medicine for HPV, laser therapy innovations, combination therapies, digital health solutions, and healthcare accessibility initiatives. Major trends in the forecast period include targeted antiviral therapies, gene editing research, biodegradable delivery systems, psychodermatology focus.
Get Your Free Sample of The Global Warts Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11959&type=smp
How have varous drivers impacted the growth of the warts therapeutics market?
The increasing focus on vaccinations for warts is expected to propel the growth of the wart’s therapeutics market going forward. Vaccination refers to the act of introducing a vaccine into the body to develop antibodies against infections and related diseases. Warts are caused by the human papillomavirus (HPV). The administration of a therapeutic or prophylactic vaccine against human papillomavirus (HPV) prevents the formation of warts. Thus, the increasing focus on vaccinations for warts is boosting the sales of the wart therapeutics market. For instance, in July 2023, according to the World Health Organization, a Switzerland-based international public health organization, in 2022, there was an improvement in the number of children who did not receive any vaccinations, commonly referred to as zero-dose children, decreasing from 18.1 million in 2021 to 14.3 million. Additionally, global coverage for the initial dose of the human papillomavirus (HPV) vaccine in girls increased from 16% in 2021 to 21% in 2022. Therefore, the increasing focus on vaccinations for warts is driving the growth of the wart therapeutics market.
What are the primary segments of the warts therapeutics market?
The warts therapeutics market covered in this report is segmented –
1) By Type: Common Warts, Genital Warts, Flat Warts, Other Types
2) By Treatment: Physical Destruction, Immunomodulation, Chemical Destruction
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows, Caused By Human Papillomavirus (HPV) Types 2 And 4
2) By Genital Warts: Occur In The Genital And Anal Areas, Primarily Caused By HPV Types 6 And 11
3) By Flat Warts: Smaller And Smoother Than Common Warts, Commonly Found On The Face, Neck, And Arms
4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose), Various HPV Types Can Cause These Warts
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report
Which firms are leading the warts therapeutics market?
Major companies operating in the warts therapeutics market include GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Novan Inc, Scholl’s Wellness Co, AIM ImmunoTech Inc., Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Nielsen BioSciences Inc., RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, KinoPharma Inc., pHion Therapeutics, Compound W, Duofilm, Curad Mediplast, Emblation Ltd.
How will industry trends affect the trajectory of the warts therapeutics market?
Product innovation is the key trend gaining popularity in the wart therapeutics market. Companies operating in the wart therapeutics market are developing innovative treatments to sustain their position in the market. For instance, in February 2023, Verrica Pharmaceuticals Inc., a US-based dermatology therapeutics company, announced that the FDA (The United States Food and Drug Administration) accepted its resubmitted New Drug Application (NDA) for VP-102 to treat molluscum contagiosum (a type of wart) and assigned a Prescription Drug User Fee Act (PDUFA) number. VP-102 is a patented drug-device combination product that delivers cantharidin (0.7% w/v) in good manufacturing practices (GMP)-controlled formulation via a single-use applicator for precise topical dosing and targeted administration.
Which geographic trends are shaping the warts therapeutics market, and which region has the highest market share?
North America was the largest region in the warts therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Warts Therapeutics Market Report 2025 Offer?
The warts therapeutics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Wart’s therapeutics refers to medical drugs and medicines that exert therapeutic effects in treating the skin condition known as warts disease, caused by the human papillomavirus (HPV). Wart therapeutics are used to treat a wide range of wart diseases caused by the hands, face, and feet.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11959
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
